ALS Research Umeå
Image: Shutterstock
Image: Shutterstock
Research network The ALS Research Center at Umeå University and University Hospital of Northern Sweden, Region Västerbotten, was established in 1993 and the associated researchers are in close collaboration with the clinical ALS team responsible for the diagnosis and treatment of patients with amyotrophic lateral sclerosis (ALS) . The research on ALS includes basic laboratory research and clinical studies, as well as pharmaceutical studies conducted in collaboration with the pharmaceutical industry.
The ALS Research Network is primarily here for patients with amyotrophic lateral sclerosis (ALS) and their next of kin, and we hope that our work will lay the groundwork for new, effective treatments to slow ALS disease progression. We believe that the key to progress is close collaboration spanning diverse fields of expertise.
Our research depends on support from, and collaboration with, members and institutions across society, including patients and their close ones, universities, health care providers, patient organisations, pharmaceutical companies, and politicians – in Sweden, in the EU, and across continents.
A unique type of eye muscle fibers is resistant against ALS, and can compensate for other muscle fibers.
Blood tests may enable more accurate diagnosis of ALS at an earlier stage of the disease, according to study.
The discovery can open up for novel pharmaceutical developments in the future.
A unique type of eye muscle fibers is resistant against ALS, and can compensate for other muscle fibers.
Blood tests may enable more accurate diagnosis of ALS at an earlier stage of the disease, according to study.
